General Information
Version
CLP_E
Revision date
2022-11-18
Product name
4-TERT-BUTYLCYCLOHEXYL CHLOROFORMATE
Chemical name
4-tert-Butylcyclohexyl chloroformate
CAS No.
42125-46-2
REACH No
01-2119472142-47-0002;
Emergency telephone
+36 80 201 199, +36 1 476 6464
Icons in SDS
Company Information
company name
Framochem French-Hungarian Fine Chemicals Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@framochem.hu
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H290, H314, H331, H412
Hazard statements
Code
Statements
H290
May be corrosive to metals
H314
Causes severe skin burns and eye damage.
H331
Toxic if inhaled
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Hazard statements
H290 – May be corrosive to metals. H314 – Causes severe skin burns and eye damage. H331 – Toxic if inhaled. H412 – Harmful to aquatic life with long lasting effects. H290 – May be corrosive to metals. H314 – Causes severe skin burns and eye damage. H331 – Toxic if inhaled. H412 – Harmful to aquatic life with long lasting effects.
2.2 Label elements
Chemical name: 4-tert-Butylcyclohexyl chloroformate CAS number: 42125-46-2 EC number: 255-670-9 DANGER
Precautionary statements
P273 – Avoid release to the environment. P280 – Wear protective gloves/protective clothing/eye protection/face protection. P284 – Wear respiratory protection. P303 + P361 + P353 – IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower. P305 + P351 + P338 – IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 – Immediately call a POISON CENTER or a doctor. P390 – Absorb spillage to prevent material damage. P406 – Store in corrosive resistant container with a resistant inner liner.
2.3 Other hazards
No other known specific hazards for human or environment. Information concerning specific hazards for human and environment: see Sections 11 and 12. The substance does not meet the PBT or vPvB criteria according to Annex XIII of Regulation